Status:

COMPLETED

Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer

Lead Sponsor:

Korea Cancer Center Hospital

Conditions:

CERVICAL NEOPLASMS

Eligibility:

FEMALE

20-75 years

Phase:

PHASE2

Brief Summary

Concurrent chemoradiation (CCRT) is the standard therapy for locally advanced cervical cancer. However, the most effective chemotherapy regimen is controversial. Weekly cisplatin, hydroxyurea + cispl...

Detailed Description

Cervical carcinoma is one of the most common gynecologic cancers worldwide. The prognosis of cervical cancer is favorable, with an approximately 80-90% 5-year survival rate in early-stage disease. How...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Histologically confirmed cervical cancer
  • Clinical stage from 2b to 4a
  • Equal to or younger than 75
  • Gog performance status 0 - 2
  • Anc \> 1500/mm3 and platelet \> 100000/mm3 and hemoglobin \> 10 g/dl
  • Serum creatinine \< 2.0
  • AST, ALT \< 3 \* upper normal level and serum bilirubin \< 1.5 mg/dl
  • Expected survival equal to or longer than 6 months
  • Who agreed to participate in this study
  • Exclusion criteria:
  • History of chemotherapy or radiation to abdomen or pelvis
  • History of other cancers
  • Pleural or pericardial effusion, ascites causing respiratory difficulties equal to or worse than NCI CTCAE grade 2
  • History of allergy or hypersensitivity reaction to platinum
  • History of atrial or ventricular arrhythmia, or congestive heart failure
  • Uncontrolled diabetes, hypertension, or ischemic heart disease
  • Myocardial infarction within 6 months
  • Sepsis or severe infection
  • Pregnant women
  • An unapproved therapy within 30 days before enrollment
  • Other serious diseases which can threat the safety of participants or impair the ability of participants to participate this trial

Exclusion

    Key Trial Info

    Start Date :

    March 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2013

    Estimated Enrollment :

    71 Patients enrolled

    Trial Details

    Trial ID

    NCT00916500

    Start Date

    March 1 2006

    End Date

    December 1 2013

    Last Update

    May 1 2014

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences

    Seoul, South Korea, 139-706